Mirtazapine Dosing: Start at 7.5 mg and Stay There
Starting mirtazapine at 7.5 mg for only three nights before dropping to 3.75 mg is not supported by evidence and contradicts FDA-approved dosing. The FDA-approved starting dose is 15 mg nightly, with dose changes made no more frequently than every 1-2 weeks 1. However, for specific indications like insomnia or when sedation is desired, 7.5 mg nightly is an appropriate and evidence-based starting dose that should be maintained, not reduced further 2, 3.
The Evidence-Based Approach
Standard Dosing (Depression)
- FDA-approved starting dose: 15 mg nightly 1
- Titrate up to maximum 45 mg daily based on response
- Dose changes should occur no more frequently than every 1-2 weeks to allow adequate time to assess response 1
Lower-Dose Strategy (Insomnia/Sedation)
Multiple clinical practice guidelines consistently recommend 7.5 mg as the starting dose when mirtazapine is used for insomnia or when sedative effects are prioritized 2, 3:
- 7.5 mg at bedtime is the established low-dose regimen 2
- Can titrate up to 30 mg for insomnia if needed 3
- This dose "promotes sleep, appetite, and weight gain" 2
- Particularly effective in patients with comorbid depression and anorexia 3
Why 3.75 mg Makes No Sense
There is no clinical evidence supporting 3.75 mg dosing:
- Research on "ultra-low-dose" mirtazapine (3.75 mg) shows only preliminary retrospective data 4
- The 7.5 mg dose has been studied in controlled trials and shows efficacy for insomnia 5
- Dropping from 7.5 mg to 3.75 mg after only 3 nights doesn't allow time to assess response and contradicts the FDA guidance requiring 1-2 weeks between dose changes 1
Clinical Algorithm
If treating depression:
- Start 15 mg nightly 1
- Wait 1-2 weeks minimum before adjusting
- Increase by 15 mg increments up to 45 mg maximum based on response
If treating insomnia (with or without depression):
- Start 7.5 mg at bedtime 2, 3
- Maintain this dose for at least 1-2 weeks 1
- If inadequate response, increase to 15 mg, then 30 mg as needed
- Do not reduce below 7.5 mg—there's no evidence base for lower dosing
If treating anxiety/agitation in palliative care:
- Start 7.5-30 mg at bedtime 3
- Adjust based on symptom control and tolerability
Critical Pitfalls to Avoid
- Don't make dose changes more frequently than every 1-2 weeks 1—you won't have adequate time to assess therapeutic response
- Don't reduce to 3.75 mg—this dose lacks evidence and may be subtherapeutic
- Don't confuse mirtazapine's paradoxical dose-response: Lower doses (7.5-15 mg) are MORE sedating due to predominant H1 antihistamine effects, while higher doses (30-45 mg) have more noradrenergic activity and may be less sedating 2
- Monitor for next-day sedation and cognitive impairment, especially in elderly patients 5
- Watch for weight gain and increased appetite, which occur at all doses 2, 5
The Bottom Line
If you started at 7.5 mg, stay at 7.5 mg for at least 1-2 weeks before making any changes. Dropping to 3.75 mg after 3 nights has no evidence base and violates basic pharmacologic principles of allowing adequate time for therapeutic assessment. The 7.5 mg dose is well-established in clinical guidelines for insomnia and sedation 2, 3, while 3.75 mg exists only in preliminary retrospective data 4.